Log In
BCIQ
Print this Print this
 

ALZ-801 (formerly BLU8499)

Also known as: formerly NRM-8499, NRM8499

  Manage Alerts
Collapse Summary General Information
Company Bellus Health Inc.
DescriptionOral small molecule prodrug of tramiprosate, an inhibitor of amyloid formation and neurotoxicity
Molecular Target Beta amyloid
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
PartnerAlzheon Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

$4.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/28/2013

Undisclosed

Undisclosed

Undisclosed

11/19/2012

Undisclosed

$4.0M

0

Get a free BioCentury trial today